Vedolizumab for induction and maintenance of remission in ulcerative colitis
Abstract
Moderate to high quality data from four studies shows that vedolizumab is superior to placebo for induction of clinical remission and response and endoscopic remission in patients with moderate to severely active ulcerative colitis and prevention of relapse in patients with quiescent ulcerative coli …
Keywords
systematic review
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
randomized controlled trials as topic
Antibodies
Monoclonal
Brian G Feagan
Humanized / therapeutic use*
Colitis
secondary prevention
pmid:25105240
doi:10.1002/14651858.cd007571.pub2
stephen j bickston
brian w behm
humanized / adverse effects
ulcerative / prevention & control
ulcerative / therapy*
induction chemotherapy / methods*
maintenance chemotherapy / methods*
Access
Citation
ID:
115472
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115472
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet